• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) NATRELLE TE SMOOTH 133S-MX-14-T; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) NATRELLE TE SMOOTH 133S-MX-14-T; EXPANDER, SKIN, INFLATABLE Back to Search Results
Model Number 133S-MX-14-T
Medical Device Problem Codes Deflation Problem (1149); Fluid/Blood Leak (1250)
Health Effect - Clinical Code Failure of Implant (1924)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: deflation.
 
Event or Problem Description
Healthcare professional reported unknown side "believed to have a leak".Device remains implanted.
 
Event or Problem Description
Healthcare professional reported left side "believed to have a leak".Device has been explanted.
 
Additional Manufacturer Narrative
Device evaluation: analysis of the returned device identified: opening curved, creases fold and brown particles on the shell.Leak test and microscopic analysis was performed which identified: striated opening on radius.Based on the device analysis the final assessment is a striated opening on radius assessed as surgical damage consistent in the use of some surgical tool.
 
Event or Problem Description
Healthcare professional reported left side "believed to have a leak".Device has been explanted.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data.
 
Event or Problem Description
Healthcare professional reported left side "believed to have a leak".Device has been explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NATRELLE TE SMOOTH 133S-MX-14-T
Common Device Name
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key11132291
Report Number9617229-2020-22193
Device Sequence Number14273688
Product Code LCJ
UDI-Device Identifier10888628044203
UDI-Public10888628044203
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K182054
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2020
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 08/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/17/2025
Device Model Number133S-MX-14-T
Device Catalogue Number133S-MX-14-T
Device Lot Number3423702
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/03/2021
Is the Reporter a Health Professional? Yes
Initial Date Received by Manufacturer 12/10/2020
Supplement Date Received by Manufacturer02/03/2021
04/13/2021
08/16/2021
Initial Report FDA Received Date01/07/2021
Supplement Report FDA Received Date03/03/2021
05/13/2021
08/30/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/17/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
Patient Weight63 KG
Patient EthnicityNon Hispanic
-
-